<em>New York Law Journal </em>notes Fried Frank's role in Sanofi-Aventis's US$20.1b acquisition of Genzyme

New York Law Journal notes Fried Frank's role in Sanofi-Aventis's US$20.1b acquisition of Genzyme

New York Law Journal reported the Firm’s representation of Goldman Sachs and Credit Suisse, financial advisors to Genzyme Corp., in connection with the purchase of Genzyme by Sanofi-Aventis SA for US$74 per share in cash, or approximately US$20.1b. Corporate partners Arthur Fleischer (NY) and Philip Richter (NY) worked on the transaction.

news-detail.inc